These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4284102)

  • 21. Systemic and coronary hemodynamic effects of isoproterenol in control animals and those pretreated with a MAO inhibitor (pargyline hydrochloride).
    McKenna DH; Afonso S; Jaramillo CV; Crumpton CW; Rowe GG
    Arch Int Pharmacodyn Ther; 1966 Aug; 162(2):275-82. PubMed ID: 5968511
    [No Abstract]   [Full Text] [Related]  

  • 22. Differential response of large and small coronary arteries to nitroglycerin and angiotensin. Autoregulation and tachyphylaxis.
    Cohen MV; Kirk ES
    Circ Res; 1973 Oct; 33(4):445-53. PubMed ID: 4355038
    [No Abstract]   [Full Text] [Related]  

  • 23. Differential effects of chromonar and nitroglycerin on intramyocardial oxygen tension.
    Weiss HR; Howe BB; Winbury MM
    Eur J Pharmacol; 1973 Jun; 22(3):249-55. PubMed ID: 4205276
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of prostaglandin A on the systemic and coronary circulations in the conscious dog.
    Higgins CB; Vatner SF; Franklin D; Patrick T; Braunwald E
    Circ Res; 1971 Jun; 28(6):638-48. PubMed ID: 4397261
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of euphyllin, papaverine, nitroglycerin and chloracizin on coronary vessel tone and myocardial oxygen consumption under isolated heart conditions (Langendorf's method)].
    Buianov VV; Kisin IE
    Vestn Akad Med Nauk SSSR; 1963; 18(1):36-41. PubMed ID: 4971963
    [No Abstract]   [Full Text] [Related]  

  • 26. [Action of glucagon on cardiac hemodynamics, coronary circulation and myocardial metabolism in humans].
    Warembourg H; Houdas Y; Bertrand ME; Ketelers JY; Vermeersch M
    Arch Mal Coeur Vaiss; 1969 Aug; 62(8):1080-95. PubMed ID: 4983769
    [No Abstract]   [Full Text] [Related]  

  • 27. The systemic and coronary hemodynamic effects of lidoflazine.
    Thomsen JH; Stenlund RR; Corliss RJ; Sialer S; Rowe GG
    Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):15-23. PubMed ID: 5650324
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological aspects of the coronary circulation.
    Parratt JR
    Prog Med Chem; 1969; 6():11-66. PubMed ID: 4307053
    [No Abstract]   [Full Text] [Related]  

  • 29. Different effects of nitroglycerin and nitroprusside on myocardial blood flow and metabolism.
    Ihlen H
    Scand J Clin Lab Invest Suppl; 1984; 173():75-9. PubMed ID: 6442005
    [No Abstract]   [Full Text] [Related]  

  • 30. Characterization of smooth muscle receptors for angiotensin: studies with an antagonist.
    Mimran A; Hinrichs KJ; Hollenberg NK
    Am J Physiol; 1974 Jan; 226(1):185-90. PubMed ID: 4358849
    [No Abstract]   [Full Text] [Related]  

  • 31. Flow and pressure responses of coronary arteries and veins to vasodilating agents.
    Sylven JC; Armour JA; Klassen GA
    Can J Physiol Pharmacol; 1984 Nov; 62(11):1365-73. PubMed ID: 6439402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative animal experimental studies of the effectivity of various blood vessel and myocardium ACTIVE SUBSTANCES IN AN ACUTE TRIAL].
    Urbaszek W; Kalkowski H; Günther K; Splith G; Trenckmann H
    Z Gesamte Inn Med; 1969 Feb; 24(4):102-8. PubMed ID: 4978753
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of catecholamine release in cardiovascular responses to angiotensin.
    Ross G; White FN
    Am J Physiol; 1966 Dec; 211(6):1419-23. PubMed ID: 4289167
    [No Abstract]   [Full Text] [Related]  

  • 34. Coronary and systemic hemodynamic effects of the putative nitric oxide donor, FK 409, in comparison with nitroglycerin in conscious and anesthetized dogs.
    Drieu la Rochelle C; Lainée P; Grosset A; O'Connor SE
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):555-63. PubMed ID: 8569215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of vasoactive drugs on local coronary flow.
    Torres EC; Brandi G
    Can J Physiol Pharmacol; 1969 May; 47(5):421-5. PubMed ID: 4306858
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiac dysfunction in the perioperative period: pathophysiology, diagnosis, and treatment.
    Lappas DG; Powell WM; Daggett WM
    Anesthesiology; 1977 Aug; 47(2):117-37. PubMed ID: 406809
    [No Abstract]   [Full Text] [Related]  

  • 37. Bioavailability studies of nitrates in the dog.
    Hastings SG
    Arch Int Pharmacodyn Ther; 1973 May; 203(1):117-22. PubMed ID: 4199057
    [No Abstract]   [Full Text] [Related]  

  • 38. Hemodynamic effects of nethalide.
    Vogin EE; Rice AJ
    Arch Int Pharmacodyn Ther; 1965 Jun; 155(2):317-25. PubMed ID: 4953960
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical trial of the new coronary dilator hexobendine].
    Henke C; Dudik E; Steim H
    Arzneimittelforschung; 1968 Aug; 18(8):1103-7. PubMed ID: 4885101
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular effects of Cassella 7657 and its interaction with adenosine, NAD and aminophylline in dogs.
    Afonso S; Hansing CE; Rowe GG
    Arch Int Pharmacodyn Ther; 1973 Dec; 206(2):299-310. PubMed ID: 4360340
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.